Literature DB >> 3138032

Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer.

Y Ogawa, M Yamamoto, S Takada, H Okada, T Shimamoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3138032     DOI: 10.1248/cpb.36.1502

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  14 in total

Review 1.  Clinical pharmacokinetics of depot leuprorelin.

Authors:  Piero Periti; Teresita Mazzei; Enrico Mini
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Solvent exchange method: a novel microencapsulation technique using dual microdispensers.

Authors:  Yoon Yeo; Alvin U Chen; Osman A Basaran; Kinam Park
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

3.  Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres.

Authors:  S Takada; T Kurokawa; K Miyazaki; S Iwasa; Y Ogawa
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

4.  Microencapsulation of hepatitis B core antigen for vaccine preparation.

Authors:  T Uchida; K Shiosaki; Y Nakada; K Fukada; Y Eda; S Tokiyoshi; N Nagareya; K Matsuyama
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

5.  Controlled release of polypeptides from polyanhydrides.

Authors:  E Ron; T Turek; E Mathiowitz; M Chasin; M Hageman; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

6.  Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.

Authors:  Christian Wischke; Ying Zhang; Sachin Mittal; Steven P Schwendeman
Journal:  Pharm Res       Date:  2010-07-29       Impact factor: 4.200

Review 7.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders.

Authors:  P Chrisp; E M Sorkin
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

8.  Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin.

Authors:  T Uchida; S Martin; T P Foster; R C Wardley; S Grimm
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

9.  Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability.

Authors:  N Nihant; C Schugens; C Grandfils; R Jérôme; P Teyssié
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

Review 10.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.